Staphylococcus aureus and its Bearing on Ophthalmic Disease

REFERENCES

• Endophthalmitis Vitrectomy Study Group. Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. Am J Ophthalmol. 1996;122(6):830–846.
   PubMed Web of Science ®Google Scholar
• Aaberg TM Jr, Flynn HW Jr, Schiffman J, et al. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology. 1998;105(6):1004–1010.
   PubMed Web of Science ®Google Scholar
• Wu PC, Kuo HK, Li M, et al. Nosocomial postoperative endophthalmitis: A 14-year review. Graefes Arch Clin Exp Ophthalmol. 2006;244(8):920–929.
   PubMed Web of Science ®Google Scholar
• Major JC Jr, Engelbert M, Flynn HW Jr, et al. Staphylococcus aureus endophthalmitis: Antibiotic susceptibilities, methicillin resistance, and clinical outcomes. Am J Ophthalmol. 2010;149(2):278–283.
   PubMed Web of Science ®Google Scholar
• Deramo VA, Lai JC, Winokur J, et al. Visual outcome and bacterial sensitivity after methicillin-resistant Staphylococcus aureus-associated acute endophthalmitis. Am J Ophthalmol. 2008;145(3):413–417.
   PubMed Web of Science ®Google Scholar
• Miller D, Flynn PM, Scott IU, et al. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol. 2006;124(4):479–483.
   PubMedGoogle Scholar
• Mwangi MM, Wu SW, Zhou Y, et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci U S A. 2007;104(22):9451–9456.
   PubMed Web of Science ®Google Scholar
• Torun MM, Bahar H, Demirci M, et al. Two heterogeneously vancomycin-intermediate clinical isolates of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in a Turkish university hospital: Brief report of a surveillance study. Int J Antimicrob Agents. 2005;26(6):508–510.
   PubMed Web of Science ®Google Scholar
• CDC. Staphylococcus aureus resistant to vancomycin–united states, 2002. MMWR Morb Mortal Wkly Rep. 2002; 51(26):565–567.
   PubMedGoogle Scholar
• Kanski JJ. Clinical Ophthalmology: A Systemic Approach. 6th edn. Edinburgh: Elsevier Butterworth-Heinemann; 2007.
   Google Scholar
• Brian G, Taylor H. Cataract blindness – challenges for the 21st century. Bull World Health Organ. 2001;79(3):249–256.
   PubMed Web of Science ®Google Scholar
• Eifrig CW, Flynn HW Jr, Scott IU, et al. Acute-onset postoperative endophthalmitis: Review of incidence and visual outcomes (1995–2001). Ophthalmic Surg Lasers. 2002;33(5):373–378.
   PubMedGoogle Scholar
• Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978–988.
   PubMed Web of Science ®Google Scholar
• West ES, Behrens A, McDonnell PJ, et al. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology. 2005;112(8):1388–1394.
   PubMed Web of Science ®Google Scholar
• Chen E, Lin MY, Cox J, et al. Endophthalmitis after intravitreal injection: The importance of viridans streptococci. Retina. 2011;31(8):1525–1533.
   PubMed Web of Science ®Google Scholar
• McCannel CA. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: Causative organisms and possible prevention strategies. Retina. 2011;31(4):654–661.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Toma HS. Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections. Arch Ophthalmol. 2011;129(9):1180–1188.
   PubMedGoogle Scholar
• Thompson JT, Parver LM, Enger CL, et al. Infectious endophthalmitis after penetrating injuries with retained intraocular foreign bodies. National Eye Trauma System. Ophthalmology. 1993;100(10):1468–1474.
   PubMed Web of Science ®Google Scholar
• Jonas JB, Knorr HL, Budde WM. Prognostic factors in ocular injuries caused by intraocular or retrobulbar foreign bodies. Ophthalmology. 2000;107(5):823–828.
   PubMed Web of Science ®Google Scholar
• Andreoli CM, Andreoli MT, Kloek CE, et al. Low rate of endophthalmitis in a large series of open globe injuries. Am J Ophthalmol. 2009;147(4):601–608.
   PubMed Web of Science ®Google Scholar
• Soheilian M, Rafati N, Peyman GA. Prophylaxis of acute posttraumatic bacterial endophthalmitis with or without combined intraocular antibiotics: A prospective, double-masked randomized pilot study. Int Ophthalmol. 2001;24(6):323–330.
   PubMedGoogle Scholar
• Ng JQ, Morlet N, Pearman JW, et al. Management and outcomes of postoperative endophthalmitis since the endophthalmitis vitrectomy study: The Endophthalmitis Population Study of Western Australia (EPSWA)’s fifth report. Ophthalmology. 2005;112(7):1199–1206.
   PubMed Web of Science ®Google Scholar
• Kunimoto DY, Das T, Sharma S, et al. Microbiologic spectrum and susceptibility of isolates: Part II. Posttraumatic endophthalmitis. endophthalmitis research group. Am J Ophthalmol. 1999;128(2):242–244.
   PubMed Web of Science ®Google Scholar
• Melo GB, Bispo PJ, Yu MC, et al. Microbial profile and antibiotic susceptibility of culture-positive bacterial endophthalmitis. Eye (Lond). 2011;25(3):382–387; quiz 388.
   PubMed Web of Science ®Google Scholar
• Chhabra S, Kunimoto DY, Kazi L, et al. Endophthalmitis after open globe injury: Microbiologic spectrum and susceptibilities of isolates. Am J Ophthalmol. 2006;142(5):852–854.
   PubMed Web of Science ®Google Scholar
• Boldt HC, Pulido JS, Blodi CF, et al. Rural endophthalmitis. Ophthalmology. 1989;96(12):1722–1726.
   PubMed Web of Science ®Google Scholar
• Sabaci G, Bayer A, Mutlu FM, et al. Endophthalmitis after deadly-weapon-related open-globe injuries: Risk factors, value of prophylactic antibiotics, and visual outcomes. Am J Ophthalmol. 2002;133(1):62–69.
   PubMed Web of Science ®Google Scholar
• Essex RW, Yi Q, Charles PG, et al. Post-traumatic endophthalmitis. Ophthalmology. 2004;111(11):2015–2022.
   PubMed Web of Science ®Google Scholar
• Azad RV, Kumar N, Sharma YR, et al. Role of prophylactic scleral buckling in the management of retained intraocular foreign bodies. Clin Experiment Ophthalmol. 2004;32(1):58–61.
   PubMed Web of Science ®Google Scholar
• Thompson WS, Rubsamen PE, Flynn HW Jr, et al. Endophthalmitis after penetrating trauma. Risk factors and visual acuity outcomes. Ophthalmology. 1995;102(11):1696–1701.
   PubMed Web of Science ®Google Scholar
• Jackson TL, Eykyn SJ, Graham EM, et al. Endogenous bacterial endophthalmitis: A 17-year prospective series and review of 267 reported cases. Surv Ophthalmol. 2003;48(4):403–423.
   PubMed Web of Science ®Google Scholar
• Havunjian RH, Goldberg RA, Hepler RS. Bilateral endogenous endophthalmitis in a patient with diabetes and renal papillary necrosis. Am J Ophthalmol. 1991;111(5):653–654.
   PubMed Web of Science ®Google Scholar
• Leibovitch I, Lai T, Raymond G, et al. Endogenous endophthalmitis: A 13-year review at a tertiary hospital in South Australia. Scand J Infect Dis. 2005;37(3):184–189.
   PubMed Web of Science ®Google Scholar
• Sheu SJ, Chou LC, Hong MC, et al. Risk factors for endogenous endophthalmitis secondary to Klebsiella pneumoniae liver abscess. Zhonghua Yi Xue Za Zhi (Taipei). 2002;65(11):534–539.
   PubMedGoogle Scholar
• Okada AA, Johnson RP, Liles WC, et al. Endogenous bacterial endophthalmitis. report of a ten-year retrospective study. Ophthalmology. 1994;101(5):832–838.
   PubMed Web of Science ®Google Scholar
• Wong JS, Chan TK, Lee HM, et al. Endogenous bacterial endophthalmitis: An East Asian experience and a reappraisal of a severe ocular affliction. Ophthalmology. 2000;107(8):1483–1491.
   PubMed Web of Science ®Google Scholar
• Ho V, Ho LY, Ranchod TM, et al. Endogenous methicillin-resistant Staphylococcus aureus endophthalmitis. Retina. 2011;31(3):596–601.
   PubMed Web of Science ®Google Scholar
• Blomquist PH. Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2006;104:322–345.
   PubMedGoogle Scholar
• Connell PP, O’Neill EC, Fabinyi D, et al. Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye (Lond). 2011;25(1):66–72.
   PubMed Web of Science ®Google Scholar
• McCarthy AJ, Lindsay JA. Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: Implications for vaccine design and host-pathogen interactions. BMC Microbiol. 2010;10:173.
   PubMed Web of Science ®Google Scholar
• O’Riordan K, Lee JC. Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev. 2004;17(1):218–234.
   PubMed Web of Science ®Google Scholar
• Sadaka A, Durand ML, Gilmore MS. Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: Host-microbe interactions in intraocular infection. Prog Retin Eye Res. 2012;31(4):316–331.
   PubMed Web of Science ®Google Scholar
• Otto M. Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu Rev Microbiol. 2010;64:143–162.
   PubMed Web of Science ®Google Scholar
• Morath S, Geyer A, Hartung T. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med. 2001;193(3):393–397.
   PubMed Web of Science ®Google Scholar
• Hashimoto M, Tawaratsumida K, Kariya H, et al. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol. 2006;177(5):3162–3169.
   PubMed Web of Science ®Google Scholar
• Bera A, Biswas R, Herbert S, et al. Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J Bacteriol. 2007;189(1):280–283.
   PubMed Web of Science ®Google Scholar
• Clarke SR, Foster SJ. Surface adhesins of Staphylococcus aureus. Adv Microb Physiol. 2006;51:187–224.
   PubMed Web of Science ®Google Scholar
• Heilmann C. Adhesion mechanisms of staphylococci. Adv Exp Med Biol. 2011;715:105–123.
   PubMed Web of Science ®Google Scholar
• Chavakis T, Wiechmann K, Preissner KT, et al. Staphylococcus aureus interactions with the endothelium: The role of bacterial ‘secretable expanded repertoire adhesive molecules’ (SERAM) in disturbing host defense systems. Thromb Haemost. 2005;94(2):278–285.
   PubMed Web of Science ®Google Scholar
• Hirschhausen N, Schlesier T, Schmidt MA, et al. A novel staphylococcal internalization mechanism involves the major autolysin Atl and heat shock cognate protein Hsc70 as host cell receptor. Cell Microbiol. 2010;12(12):1746–1764.
   PubMed Web of Science ®Google Scholar
• Biswas R, Voggu L, Simon UK, et al. Activity of the major staphylococcal autolysin Atl. FEMS Microbiol Lett. 2006;259(2):260–268.
   PubMed Web of Science ®Google Scholar
• Xu KD, McFeters GA, Stewart PS. Biofilm resistance to antimicrobial agents. Microbiology. 2000;146 (Pt 3):547–549.
   PubMed Web of Science ®Google Scholar
• De Beer D, Srinivasan R, Stewart PS. Direct measurement of chlorine penetration into biofilms during disinfection. Appl Environ Microbiol. 1994;60(12):4339–4344.
   PubMed Web of Science ®Google Scholar
• Heilmann C, Schweitzer O, Gerke C, et al. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol Microbiol. 1996;20(5):1083–1091.
   PubMed Web of Science ®Google Scholar
• Jefferson KK, Pier DB, Goldmann DA, et al. The teicoplanin-associated locus regulator (TcaR) and the intercellular adhesin locus regulator (IcaR) are transcriptional inhibitors of the ica locus in Staphylococcus aureus. J Bacteriol. 2004;186(8):2449–2456.
   PubMed Web of Science ®Google Scholar
• Cramton SE, Ulrich M, Gotz F, et al. Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun. 2001;69(6):4079–4085.
   PubMed Web of Science ®Google Scholar
• Vergara-Irigaray M, Valle J, Merino N, et al. Relevant role of fibronectin-binding proteins in Staphylococcus aureus biofilm-associated foreign-body infections. Infect Immun. 2009;77(9):3978–3991.
   PubMed Web of Science ®Google Scholar
• O’Neill E, Pozzi C, Houston P, et al. A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J Bacteriol. 2008;190(11):3835–3850.
   PubMed Web of Science ®Google Scholar
• Baillif S, Ecochard R, Casoli E, et al. Adherence and kinetics of biofilm formation of Staphylococcus epidermidis to different types of intraocular lenses under dynamic flow conditions. J Cataract Refract Surg. 2008;34(1):153–158.
   PubMed Web of Science ®Google Scholar
• Nagaki Y, Hayasaka S, Kadoi C, et al. Bacterial endophthalmitis after small-incision cataract surgery. Effect of incision placement and intraocular lens type. J Cataract Refract Surg. 2003;29(1):20–26.
   PubMed Web of Science ®Google Scholar
• Callegan MC, Engelbert M, Parke DW, et al. Bacterial endophthalmitis: Epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev. 2002;15(1):111–124.
   PubMed Web of Science ®Google Scholar
• Lin YC, Peterson ML. New insights into the prevention of staphylococcal infections and toxic shock syndrome. Expert Rev Clin Pharmacol. 2010;3(6):753–767.
   PubMed Web of Science ®Google Scholar
• Beyer TL, Vogler G, Sharma D, et al. Protective barrier effect of the posterior lens capsule in exogenous bacterial endophthalmitis – an experimental primate study. Invest Ophthalmol Vis Sci. 1984;25(1):108–112.
   PubMed Web of Science ®Google Scholar
• Engelbert M, Gilmore MS. Fas ligand but not complement is critical for control of experimental Staphylococcus aureus endophthalmitis. Invest Ophthalmol Vis Sci. 2005;46(7):2479–2486.
   PubMed Web of Science ®Google Scholar
• Whiston EA, Sugi N, Kamradt MC, et al. alphaB-crystallin protects retinal tissue during Staphylococcus aureus-induced endophthalmitis. Infect Immun. 2008;76(4):1781–1790.
   PubMed Web of Science ®Google Scholar
• Haynes RJ, McElveen JE, Dua HS, et al. Expression of human beta-defensins in intraocular tissues. Invest Ophthalmol Vis Sci. 2000;41(10):3026–3031.
   PubMed Web of Science ®Google Scholar
• Chang JH, McCluskey PJ, Wakefield D. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br J Ophthalmol. 2006;90(1):103–108.
   PubMed Web of Science ®Google Scholar
• Uhlen M, Guss B, Nilsson B, et al. Complete sequence of the staphylococcal gene encoding protein A. A gene evolved through multiple duplications. J Biol Chem. 1984;259(3):1695–1702.
   PubMed Web of Science ®Google Scholar
• Ashley DJ, Brindle MJ. Penicillin resistance in staphylococci isolated in a casualty department. J Clin Pathol. 1960;13:336–338.
   PubMed Web of Science ®Google Scholar
• Jevons MP, Coe AW, Parker MT. Methicillin resistance in staphylococci. Lancet. 1963;1(7287):904–907.
   PubMed Web of Science ®Google Scholar
• Chambers HF. Methicillin resistance in staphylococci: Molecular and biochemical basis and clinical implications. Clin Microbiol Rev. 1997;10(4):781–791.
   PubMed Web of Science ®Google Scholar
• Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the united states. JAMA. 2007;298(15):1763–1771.
   PubMed Web of Science ®Google Scholar
• Antimicrobial resistance surveillance in Europe: Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-net). 2009.
   Google Scholar
• Lamaris GA, Esmaeli B, Chamilos G, et al. Fungal endophthalmitis in a tertiary care cancer center: A review of 23 cases. Eur J Clin Microbiol Infect Dis. 2008;27(5):343–347.
   PubMed Web of Science ®Google Scholar
• Zetola N, Francis JS, Nuermberger EL, et al. Community-acquired meticillin-resistant Staphylococcus aureus: An emerging threat. Lancet Infect Dis. 2005;5(5):275–286.
   PubMed Web of Science ®Google Scholar
• Francis JS, Doherty MC, Lopatin U, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-valentine leukocidin genes. Clin Infect Dis. 2005;40(1):100–107.
   PubMed Web of Science ®Google Scholar
• Enright MC, Robinson DA, Randle G, et al. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A. 2002;99(11):7687–7692.
   PubMed Web of Science ®Google Scholar
• Etienne J, Dumitrescu O. Panton-valentine leucocidin associated Staphylococcus aureus infections. BMJ. 2009;339:b4083.
   PubMed Web of Science ®Google Scholar
• Zhang K, McClure JA, Elsayed S, et al. Novel staphylococcal cassette chromosome mec type, tentatively designated type VIII, harboring class A mec and type 4 ccr gene complexes in a Canadian epidemic strain of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2009;53(2):531–540.
   PubMed Web of Science ®Google Scholar
• Tsuji BT, Rybak MJ, Cheung CM, et al. Community- and health care-associated methicillin-resistant Staphylococcus aureus: A comparison of molecular epidemiology and antimicrobial activities of various agents. Diagn Microbiol Infect Dis. 2007;58(1):41–47.
   PubMed Web of Science ®Google Scholar
• Hesje CK, Sanfilippo CM, Haas W, et al. Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolated from the eye. Curr Eye Res. 2011;36(2):94–102.
   PubMed Web of Science ®Google Scholar
• Ito T, Kuwahara K, Hiramatsu K. Staphylococcal cassette chromosome mec(SCC mec) analysis of MRSA. Methods Mol Biol. 2007;391:87–102.
   PubMedGoogle Scholar
• Holden MT, Feil EJ, Lindsay JA, et al. Complete genomes of two clinical Staphylococcus aureus strains: Evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A. 2004;101(26):9786–9791.
   PubMed Web of Science ®Google Scholar
• Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet. 2006;367(9512):731–739.
   PubMed Web of Science ®Google Scholar
• Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med. 2005;352(5):468–475.
   PubMed Web of Science ®Google Scholar
• Tenover FC, McDougal LK, Goering RV, et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol. 2006;44(1):108–118.
   PubMed Web of Science ®Google Scholar
• Rutar T, Chambers HF, Crawford JB, et al. Ophthalmic manifestations of infections caused by the USA300 clone of community-associated methicillin-resistant Staphylococcus aureus. Ophthalmology. 2006;113(8):1455–1462.
   PubMed Web of Science ®Google Scholar
• Booth MC, Pence LM, Mahasreshti P, et al. Clonal associations among Staphylococcus aureus isolates from various sites of infection. Infect Immun. 2001;69(1):345–352.
   PubMed Web of Science ®Google Scholar
• Pierre DJ, Tang J. Bleb associated endophthalmitis with methicillin-resistant Staphylococcus aureus. Br J Ophthalmol. 2010;94(3):390–392.
   PubMed Web of Science ®Google Scholar
• Fukuda M, Ohashi H, Matsumoto C, et al. Methicillin-resistant staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection efficacy of chloramphenicol eye drops. Cornea. 2002;21(7 Suppl):S86–S89.
   PubMed Web of Science ®Google Scholar
• Rarey KA, Shanks RM, Romanowski EG, et al. Staphylococcus aureus isolated from endophthalmitis are hospital-acquired based on Panton-valentine leukocidin and antibiotic susceptibility testing. J Ocul Pharmacol Ther. 2011.
   Google Scholar
• Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics. 2005;115(3):642–648.
   PubMed Web of Science ®Google Scholar
• Freidlin J, Acharya N, Lietman TM, et al. Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus. Am J Ophthalmol. 2007;144(2):313–315.
   PubMed Web of Science ®Google Scholar
• Jensen HG, Felix C. In vitro antibiotic susceptibilities of ocular isolates in North and South America. In vitro antibiotic testing group. Cornea. 1998;17(1):79–87.
   PubMed Web of Science ®Google Scholar
• Cavuoto K, Zutshi D, Karp CL, et al. Update on bacterial conjunctivitis in south Florida. Ophthalmology. 2008;115(1):51–56.
   PubMed Web of Science ®Google Scholar
• Haas W, Pillar CM, Torres M, et al. Monitoring antibiotic resistance in ocular microorganisms: Results from the antibiotic resistance monitoring in ocular MicRorganisms (ARMOR) 2009 surveillance study. Am J Ophthalmol. 2011.
   Google Scholar
• Asbell PA, Sahm DF, Shaw M, et al. Increasing prevalence of methicillin resistance in serious ocular infections caused by Staphylococcus aureus in the united states: 2000 to 2005. J Cataract Refract Surg. 2008;34(5):814–818.
   PubMed Web of Science ®Google Scholar
• Asbell PA, Colby KA, Deng S, et al. Ocular TRUST: Nationwide antimicrobial susceptibility patterns in ocular isolates. Am J Ophthalmol. 2008;145(6):951–958.
   PubMed Web of Science ®Google Scholar
• Hwang DG. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol. 2004;49(Suppl 2):S79–S83.
   Web of Science ®Google Scholar
• Cheng D, Xu WR, Liu CX. Relationship of quantitative structure and pharmacokinetics in fluoroquinolone antibacterials. World J Gastroenterol. 2007;13(17):2496–2503.
   PubMed Web of Science ®Google Scholar
• Marangon FB, Miller D, Muallem MS, et al. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. Am J Ophthalmol. 2004;137(3):453–458.
   PubMed Web of Science ®Google Scholar
• Donnenfeld ED, Comstock TL, Proksch JW. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application. J Cataract Refract Surg. 2011;37(6):1082–1089.
   PubMed Web of Science ®Google Scholar
• Singh S, Katiyar R, Kaistha SD. High oxacillin, vancomycin and fluoroquinolone resistance amongst biofilm forming Staphylococcus aureus isolates from ulcerative keratitis infections. Indian J Med Microbiol. 2011;29(3):312–313.
   PubMed Web of Science ®Google Scholar
• Boles BR, Horswill AR. Staphylococcal biofilm disassembly. Trends Microbiol. 2011.
   PubMed Web of Science ®Google Scholar
• Behlau I, Mukherjee K, Todani A, et al. Biocompatibility and biofilm inhibition of N,N-hexyl,methyl-polyethylenimine bonded to Boston keratoprosthesis materials. Biomaterials. 2011;32(34):8783–8796.
   PubMed Web of Science ®Google Scholar
• Dean SN, Bishop BM, van Hoek ML. Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against staphylococcus aureus. BMC Microbiol. 2011;11:114.
   PubMed Web of Science ®Google Scholar
• Wright JS 3rd, Jin R, Novick RP. Transient interference with staphylococcal quorum sensing blocks abscess formation. Proc Natl Acad Sci U S A. 2005;102(5):1691–1696.
   PubMed Web of Science ®Google Scholar
• Corbin BD, Seeley EH, Raab A, et al. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science. 2008;319(5865):962–965.
   PubMed Web of Science ®Google Scholar
• Ruzin A, Novick RP. Equivalence of lauric acid and glycerol monolaurate as inhibitors of signal transduction in staphylococcus aureus. J Bacteriol. 2000;182(9):2668–2671.
   PubMed Web of Science ®Google Scholar
• Holland KT, Taylor D, Farrell AM. The effect of glycerol monolaurate on growth of, and production of toxic shock syndrome toxin-1 and lipase by Staphylococcus aureus. J Antimicrob Chemother. 1994;33(1):41–55.
   PubMed Web of Science ®Google Scholar
• Schlievert PM, Deringer JR, Kim MH, et al. Effect of glycerol monolaurate on bacterial growth and toxin production. Antimicrob Agents Chemother. 1992;36(3):626–631.
   PubMed Web of Science ®Google Scholar
• Peterson ML, Schlievert PM. Glycerol monolaurate inhibits the effects of Gram-positive select agents on eukaryotic cells. Biochemistry. 2006;45(7):2387–2397.
   PubMed Web of Science ®Google Scholar
• Culos KA, Cannon JP, Grim SA. Alternative agents to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Am J Ther. 2011.
   Web of Science ®Google Scholar
• Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18–e55.
   PubMed Web of Science ®Google Scholar
• Steed E, Rybak J. Ceftaroline: A new cephalosporin with activity against resistant Gram-positive pathogens. Pharmacotherapy. 2010;30:375.
   PubMed Web of Science ®Google Scholar
• Watanabe A, Goto H, Soma K, et al. Usefulness of linezolid in the treatment of hospital-acquired pneumonia caused by MRSA: A prospective observational study. J Infect Chemother. 2011.
   Google Scholar
• Swaney SM, Aoki H, Ganoza MC, et al. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother. 1998;42(12):3251–3255.
   PubMed Web of Science ®Google Scholar
• Stevens DL, Ma Y, Salmi DB, et al. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis. 2007;195(2):202–211.
   PubMed Web of Science ®Google Scholar
• Saleh M, Jehl F, Dory A, et al. Ocular penetration of topically applied linezolid in a rabbit model. J Cataract Refract Surg. 2010;36(3):488–492.
   PubMed Web of Science ®Google Scholar
• George JM, Fiscella R, Blair M, et al. Aqueous and vitreous penetration of linezolid and levofloxacin after oral administration. J Ocul Pharmacol Ther. 2010;26(6):579–586.
   PubMed Web of Science ®Google Scholar
• Tappeiner C, Schuerch K, Goldblum D, et al. Combined meropenem and linezolid as a systemic treatment for postoperative endophthalmitis. Klin Monbl Augenheilkd. 2010;227(4):257–261.
   PubMed Web of Science ®Google Scholar
• Duke SL, Kump LI, Yuan Y, et al. The safety of intraocular linezolid in rabbits. Invest Ophthalmol Vis Sci. 2010;51(6):3115–3119.
   PubMed Web of Science ®Google Scholar
• Falcone M, Russo A, Pompeo ME, et al. Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy. Int J Antimicrob Agents. 2011.
   PubMed Web of Science ®Google Scholar
• Sheridan KR, Potoski BA, Shields RK, et al. Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitis. Pharmacotherapy. 2010;30(12):1247–1251.
   PubMed Web of Science ®Google Scholar
• Comer GM, Miller JB, Schneider EW, et al. Intravitreal daptomycin: a safety and efficacy study. Retina. 2011.
   PubMed Web of Science ®Google Scholar
• Lefevre S, Saleh M, Marcellin L, et al. Daptomycin versus vancomycin in a methicillin-resistant Staphylococcus aureus endophthalmitis rabbit model: Bactericidal effect, safety and ocular pharmacokinetics. Antimicrob Agents Chemother. 2012.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Campbell J, Swoboda JG, et al. Role of wall teichoic acids in Staphylococcus aureus endophthalmitis. Invest Ophthalmol Vis Sci. 2011;52(6):3187–3192.
   PubMed Web of Science ®Google Scholar
• Schindler CA, Schuhardt VT. Lysostaphin: A new bacteriolytic agent for the Staphylococcus. Proc Natl Acad Sci U S A. 1964;51:414–421.
   PubMed Web of Science ®Google Scholar
• Balzli CL, McCormick CC, Caballero AR, et al. Sustained anti-staphylococcal effect of lysostaphin in the rabbit aqueous humor. Curr Eye Res. 2010;35(6):480–486.
   PubMed Web of Science ®Google Scholar
• Dajcs JJ, Thibodeaux BA, Hume EB, et al. Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit. Curr Eye Res. 2001;22(6):451–457.
   PubMed Web of Science ®Google Scholar
• Dajcs JJ, Thibodeaux BA, Girgis DO, et al. Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit. Invest Ophthalmol Vis Sci. 2002;43(12):3712–3716.
   PubMed Web of Science ®Google Scholar
• Kessler E, Safrin M, Olson JC, et al. Secreted LasA of pseudomonas aeruginosa is a staphylolytic protease. J Biol Chem. 1993;268(10):7503–7508.
   PubMed Web of Science ®Google Scholar
• American Academy of Ophthalmology. Cataract/Anterior segment. Cataract and anterior segment preferred practice pattern. 2011.
   Google Scholar
• Ferguson AW, Scott JA, McGavigan J, et al. Comparison of 5% povidone-iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: A prospective randomised double blind study. Br J Ophthalmol. 2003;87(2):163–167.
   PubMed Web of Science ®Google Scholar
• Mino de Kaspar H, Chang RT, Singh K, et al. Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery. Arch Ophthalmol. 2005;123(2):161–165.
   PubMedGoogle Scholar
• Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98(12):1769–1775.
   PubMed Web of Science ®Google Scholar
• Gungor SG, Akova YA, Bozkurt A, et al. Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery. Br J Ophthalmol. 2011;95(9):1272–1275.
   PubMed Web of Science ®Google Scholar
• Ong-Tone L. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery. J Cataract Refract Surg. 2007;33(1):59–62.
   PubMed Web of Science ®Google Scholar
• Moss JM, Sanislo SR, Ta CN. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology. 2009;116(8):1498–1501.
   PubMed Web of Science ®Google Scholar
• Montan PG, Wejde G, Koranyi G, et al. Prophylactic intracameral cefuroxime. efficacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg. 2002;28(6):977–981.
   PubMed Web of Science ®Google Scholar
• Romero P, Mendez I, Salvat M, et al. Intracameral cefazolin as prophylaxis against endophthalmitis in cataract surgery. J Cataract Refract Surg. 2006;32(3):438–441.
   PubMed Web of Science ®Google Scholar
• Murjaneh S, Waqar S, Hale JE, et al. National survey of the use of intraoperative antibiotics for prophylaxis against postoperative endophthalmitis following cataract surgery in the UK. Br J Ophthalmol. 2010;94(10):1410–1411.
   PubMed Web of Science ®Google Scholar
• Wykoff CC, Parrott MB, Flynn HW Jr, et al. Nosocomial acute-onset postoperative endophthalmitis at a university teaching hospital (2002–2009). Am J Ophthalmol. 2010;150(3):392–398.
   PubMed Web of Science ®Google Scholar
• Kodjikian L, Couprie J, Hachicha W, et al. Experimental intracameral injection of vancomycin microparticles in rabbits. Invest Ophthalmol Vis Sci. 2010.
   Google Scholar
• Cardillo JA, Paganelli F, Melo LA Jr, et al. Subconjunctival delivery of antibiotics in a controlled-release system: A novel anti-infective prophylaxis approach for cataract surgery. Arch Ophthalmol. 2010;128(1):81–87.
   PubMedGoogle Scholar
• Peng YJ, Kau YC, Wen CW, et al. Solvent-free biodegradable scleral plugs providing sustained release of vancomycin, amikacin, and dexamethasone – an in vivo study. J Biomed Mater Res A. 2010;94(2):426–432.
   PubMed Web of Science ®Google Scholar
• Taravella MJ, Balentine J, Young DA, et al. Collagen shield delivery of ofloxacin to the human eye. J Cataract Refract Surg. 1999;25(4):562–565.
   PubMed Web of Science ®Google Scholar
• Uhart M, Pirot F, Boillon A, et al. Assessment of sodium hyaluronate gel as vehicle for intracameral delivery of cefuroxime in endophthalmitis prophylaxis. Int J Pharm. 2010;398(1–2):14–20.
   PubMed Web of Science ®Google Scholar
• Barequet IS, Habot-Wilner Z, Mann O, et al. Evaluation of Pseudomonas aeruginosa staphylolysin (LasA protease) in the treatment of methicillin-resistant Staphylococcus aureus endophthalmitis in a rat model. Graefes Arch Clin Exp Ophthalmol. 2009;247(7):913–917.
   PubMed Web of Science ®Google Scholar
• Vandersteegen K, Mattheus W, Ceyssens PJ, et al. Microbiological and molecular assessment of bacteriophage ISP for the control of staphylococcus aureus. PLoS One. 2011;6(9):e24418.
   PubMed Web of Science ®Google Scholar
• Alfadhel M, Puapermpoonsiri U, Ford SJ, et al. Lyophilized inserts for nasal administration harboring bacteriophage selective for Staphylococcus aureus: In vitro evaluation. Int J Pharm. 2011;416(1):280–287.
   PubMed Web of Science ®Google Scholar
• Pastagia M, Euler C, Chahales P, et al. A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains. Antimicrob Agents Chemother. 2011;55(2):738–744.
   PubMed Web of Science ®Google Scholar